Feiyu Chen

1.7k total citations
37 papers, 1.1k citations indexed

About

Feiyu Chen is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Feiyu Chen has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Cancer Research and 6 papers in Organic Chemistry. Recurrent topics in Feiyu Chen's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (8 papers). Feiyu Chen is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (8 papers). Feiyu Chen collaborates with scholars based in China, Hong Kong and United States. Feiyu Chen's co-authors include Ning Wang, Yibin Feng, Hor‐Yue Tan, Wei Guo, Cheng Zhang, Jihan Huang, Fan Cheung, Zhangfeng Zhong, Kejing Zhang and Zheng Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Free Radical Biology and Medicine.

In The Last Decade

Feiyu Chen

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feiyu Chen China 20 731 493 163 112 85 37 1.1k
Lei Bi China 17 543 0.7× 215 0.4× 218 1.3× 95 0.8× 53 0.6× 46 977
Huayao Li China 22 731 1.0× 422 0.9× 199 1.2× 131 1.2× 76 0.9× 55 1.2k
Alok Ranjan United States 18 610 0.8× 221 0.4× 242 1.5× 70 0.6× 74 0.9× 38 1.1k
Naoshad Muhammad United States 15 459 0.6× 316 0.6× 134 0.8× 84 0.8× 52 0.6× 26 799
Shilpa Kuttikrishnan Qatar 21 781 1.1× 240 0.5× 257 1.6× 111 1.0× 45 0.5× 46 1.2k
Anuradha Kirtonia India 10 563 0.8× 284 0.6× 173 1.1× 71 0.6× 43 0.5× 12 904
Mengqiu Song China 16 799 1.1× 231 0.5× 263 1.6× 127 1.1× 75 0.9× 38 1.3k
Elham Baghbani Iran 19 756 1.0× 487 1.0× 275 1.7× 190 1.7× 32 0.4× 55 1.2k

Countries citing papers authored by Feiyu Chen

Since Specialization
Citations

This map shows the geographic impact of Feiyu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiyu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiyu Chen more than expected).

Fields of papers citing papers by Feiyu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feiyu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiyu Chen. The network helps show where Feiyu Chen may publish in the future.

Co-authorship network of co-authors of Feiyu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Feiyu Chen. A scholar is included among the top collaborators of Feiyu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feiyu Chen. Feiyu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Tao, Feiyu Chen, Chao Lou, et al.. (2025). MOTS-c attenuates mitochondrial dysfunction induces pyroptosis and cartilage degradation in osteoarthritis via an Nrf2-Dependent Mechanism. Free Radical Biology and Medicine. 241. 717–731.
2.
Huang, Jihan, Feiyu Chen, Hor‐Yue Tan, et al.. (2024). Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies. Phytomedicine. 133. 155905–155905. 8 indexed citations
3.
Zhou, Zhiyang, Yukun Cao, Yuan Yang, Shouman Wang, & Feiyu Chen. (2023). METTL3-mediated m 6 A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis. Epigenetics. 18(1). 2217033–2217033. 11 indexed citations
4.
Hu, Jie, Weifeng Liu, Xiangyu Zhang, et al.. (2023). Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1. Hepatology International. 17(5). 1265–1278. 16 indexed citations
5.
Li, Liping, Min Li, Shiyu Sun, et al.. (2022). Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo. Frontiers in Cell and Developmental Biology. 10. 809922–809922. 4 indexed citations
6.
Zhang, Xiangyu, Feiyu Chen, Xinyu Wang, et al.. (2022). Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma. International Journal of Biological Sciences. 18(6). 2249–2260. 45 indexed citations
7.
Wang, Ning, Hor‐Yue Tan, Yuanjun Lu, et al.. (2021). PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma. Signal Transduction and Targeted Therapy. 6(1). 86–86. 44 indexed citations
8.
Zhang, Kejing, Lili Tang, Yuan Yang, et al.. (2021). Association Between Single-Nucleotide Polymorphisms in Breast Cancer Susceptibility Genes and Clinicopathological Characteristics. Clinical Epidemiology. Volume 13. 103–112. 4 indexed citations
9.
Pang, Jian, et al.. (2021). lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis. Molecular Therapy — Oncolytics. 21. 62–73. 19 indexed citations
10.
Chen, Feiyu, Zhangfeng Zhong, Hor‐Yue Tan, et al.. (2020). Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3p. SHILAP Revista de lepidopterología. 10(6). 48 indexed citations
11.
12.
Huang, Jihan, Feiyu Chen, Zhangfeng Zhong, et al.. (2020). Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation. Frontiers in Pharmacology. 11. 414–414. 37 indexed citations
13.
14.
Li, Xiang, Feiyu Chen, Jin Zhou, et al.. (2019). Stereoselective Assembly of Multifunctional Spirocyclohexene Pyrazolones That Induce Autophagy-Dependent Apoptosis in Colorectal Cancer Cells. The Journal of Organic Chemistry. 84(14). 9138–9150. 40 indexed citations
15.
Guo, Wei, Jihan Huang, Ning Wang, et al.. (2019). Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma. Frontiers in Pharmacology. 10. 1185–1185. 170 indexed citations
16.
Li, Xiang, Yanqing Liu, Feiyu Chen, et al.. (2018). Synthesis of Vinylcyclopropane‐Fused Pyrazolone Derivatives by Sulfur Ylide‐Initiated 1,6‐Michael Addition‐Cyclization Reactions. European Journal of Organic Chemistry. 2018(34). 4723–4730. 5 indexed citations
17.
Wang, Ning, Hor‐Yue Tan, Yigang Feng, et al.. (2018). microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance. Cancers. 11(1). 7–7. 82 indexed citations
18.
Yuan, Jiaqi, Jie Mao, Yuhui Wu, et al.. (2015). Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 151(2). 405–413. 22 indexed citations
19.
Wang, Shouman, Feiyu Chen, & Lili Tang. (2014). IL-32 promotes breast cancer cell growth and invasiveness. Oncology Letters. 9(1). 305–307. 31 indexed citations
20.
Chen, Feiyu, Lili Tang, Ting Xia, et al.. (2013). Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer. Molecular and Clinical Oncology. 1(5). 894–902. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Bi Breakdown of academic impact, for papers by Huayao Li Breakdown of academic impact, for papers by Alok Ranjan Breakdown of academic impact, for papers by Naoshad Muhammad Breakdown of academic impact, for papers by Shilpa Kuttikrishnan Breakdown of academic impact, for papers by Anuradha Kirtonia Breakdown of academic impact, for papers by Mengqiu Song Breakdown of academic impact, for papers by Elham Baghbani
Rankless by CCL
2026